Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesA double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis
Annals of Oncology, 07/22/09
Leyssens B et al. – The incidence of dacryostenosis in patients receiving weekly docetaxel was not different for the AT– and the CS–treated eyes. The dacryostenosis was predominantly mild, not leading to surgical interventions.
Related Articles
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity
The Prostate, 11/02/09
Relevance Score: 40%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration
Journal of Clinical Ultrasound, 12/03/09
N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients
American Journal of Therapeutics, 12/02/09
Photodynamic Therapy With and Without Adjunctive Intravitreal Triamcinolone Acetonide
Ophthalmic Surgery, Lasers and Imaging, 12/01/09
Article Search
Sponsor